A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

Condition:   Schizophrenia Interventions:   Drug: ASP4345;   Drug: placebo;   Drug: risperidone;   Drug: quetiapine;   Drug: olanzapine;   Drug: ziprasidone;   Drug: aripiprazole;   Drug: brexpiprazole;   Drug: paliperidone;   Drug: lurasidone Sponsor:   Astellas Pharma Global Development, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials